TABLE 3.
Anti-SIV IgG responses in infant rhesus macaques following inoculation with SIVmac055 or SIVmac385
Animal group | Animal no. | SIVa | PMPAb | Anti-SIV IgG titer at the following times (wk) after virus inoculationc:
|
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 2 | 3 | 4 | 6 | 7–8 | 10 | 12–13 | 14–16 | 18–21 | 30 | 39 | ||||
A | 29668 | 055 | − | <100 | <100 | <100 | <100 | <100 | <100 | <100 | 400 | <100d | |||
29669 | 055 | − | <100 | <100 | <100 | <100 | <100 | <100d | |||||||
29670 | 055 | − | <100 | <100 | <100 | <100 | <100 | <100d | |||||||
B | 29674 | 385 | − | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100d | ||||
29675 | 385 | − | <100 | <100 | <100 | <100 | <100 | <100 | <100d | ||||||
29729 | 385 | − | <100 | <100 | <100 | <100 | <100 | <100d | |||||||
C | 29283 | 055 | + | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100d |
29360 | 055 | + | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100d | |||
29419 | 055 | + | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100 | <100d | |||
D | 29276 | 385 | + | <100 | <100 | 100 | 1,600 | 25,600 | 25,600 | 25,600 | 25,600 | 25,600 | 102,400 | 102,400 | 102,400 |
29278 | 385 | + | <100 | <100 | 100 | 1,600 | 25,600 | 25,600 | 25,600 | 25,600 | 6,400 | 25,600 | 102,400 | 102,400 | |
29279 | 385 | + | <100 | <100 | <100 | <100 | 6,400 | 6,400 | 6,400 | 25,600 | 25,600 | 102,400 | 102,400 | 102,400 |
Animals were inoculated at birth with SIVmac055 (055) or SIVmac385 (385).
Groups C and D were started on PMPA treatment 3 weeks after virus inoculation.
Anti-SIV IgG titers at the indicated times after virus inoculation were determined by ELISA and are expressed as the reciprocal of the highest of fourfold dilutions (starting from a 1/100 dilution with two replicates per dilution) which gave a positive optical density above the cutoff value. Significant titers (titer, ≥400) are indicated in boldface.
Time of death.